Pharming Group NV Cash Flow Quality Index
Pharming Group NV cash flow quality index. Pharming Group NV (PHARM) has a Cash Flow Quality Index of 2.51x as of September 2025. Operating cash flow of €32.03 Million exceeds net income of €12.76 Million, indicating high earnings quality where cash backs reported profits. See PHARM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pharming Group NV (2017–2022)
Cash flow quality index of Pharming Group NV from 2017 to 2022. Historical Cash Flow Quality Index for Pharming Group NV across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PHARM cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Pharming Group NV Cash Flow Quality Index by Year (2017–2022)
Pharming Group NV cash flow quality index by year from 2017 to 2022. Year-by-year earnings quality comparison for Pharming Group NV. For the full cash flow conversion analysis, see Pharming Group NV cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.53x | €22.90 Million | €14.99 Million | ▼ -6.8% |
| 2021 | 1.64x | €36.13 Million | €22.03 Million | ▼ -14.5% |
| 2020 | 1.92x | €90.98 Million | €47.47 Million | ▲ +75.4% |
| 2019 | 1.09x | €74.56 Million | €68.23 Million | ▲ +2.8% |
| 2018 | 1.06x | €46.19 Million | €43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | €45.84 Million | €26.29 Million | — |